Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 8/20 | 0.37 |
| ▸ | CES1 | P23141 | 6/20 | 0.36 |
| ▸ | FDPS | P14324 | 4/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17510336 | 1.00 | CES2 (0.43) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL45377 | 0.97 | CES2 (0.46) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL6037238 | 0.97 | CES2 (0.46) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL30892683 | 0.97 | CES2 (0.46) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL22268683 | 0.97 | CES2 (0.46) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL17510328 | 0.97 | CES2 (0.46) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL45268 | 0.97 | CES2 (0.46) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL17136266 | 0.91 | TSHR (0.35) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL1221382 | 0.91 | TSHR (0.35) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL19322682 | 0.84 | CES1 (0.53) | CES2LPAR1LPAR3TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021212512-A1 | BATTERY COOLANT AND BATTERY ENCAPSULATION STRUCTURE | 东莞新能德科技有限公司 (CN) | 2021-10-28 | — | — | WO | claimed |
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
| WO-2022140252-A1 | NANOMATERIALS COMPRISING ESTER-LINKED ACETALS | BEAM THERAPEUTICS INC. (US) | 2022-06-30 | — | — | WO | disclosed |
| US-9657124-B2 | Halogen copolymers comprising at least one repetitive vinyl ether unit having one carbonate pendant group | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-05-23 | — | — | US | disclosed |
| US-9562122-B2 | Compound, resin, resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20160053032-A1 | COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-02-25 | — | — | US | disclosed |
| US-20150191761-A1 | USE OF HIGH FLUX SCFA-DERIVATIZED MONOSACCHARIDES IN RECOMBINANT GLYCOPROTEIN PRODUCTION | THE JOHNS HOPKINS UNIVERSITY | 2015-07-09 | — | — | US | disclosed |
| EP-2627682-B1 | HALOGENATED COPOLYMERS COMPRISING AT LEAST ONE VINYL ETHER REPEAT UNIT BEARING A CARBONATE PENDENT GROUP | COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2015-05-13 | — | — | EP | disclosed |
| US-20130280620-A1 | HALOGEN COPOLYMERS COMPRISING AT LEAST ONE REPETITIVE VINYL ETHER UNIT HAVING ONE CARBONATE PENDANT GROUP | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2013-10-24 | — | — | US | disclosed |
| EP-2627682-A1 | HALOGENATED COPOLYMERS COMPRISING AT LEAST ONE VINYL ETHER REPEAT UNIT BEARING A CARBONATE PENDENT GROUP | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2013-08-21 | — | — | EP | disclosed |
| US-20120157421-A1 | 17Beta-Alkyl-17Alpha-oxy-estratrienes | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2012-06-21 | — | — | US | disclosed |
| WO-2012049070-A1 | HALOGENATED COPOLYMERS COMPRISING AT LEAST ONE VINYL ETHER REPEAT UNIT BEARING A CARBONATE PENDENT GROUP | Commissariat à l'énergie atomique et aux énergies alternatives (FR) | 2012-04-19 | — | — | WO | disclosed |
| WO-2010139411-A2 | 17β-ALKYL-17α-OXY-ESTRATRIENES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-12-09 | — | — | WO | disclosed |
| EP-2258375-A1 | 17B-alkyl-17alpha-oxy-estratrienes | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | CYP2B6, CBR3, CYP2A6 | CES2 256/4885LPAR1 3744/4885LPAR3 2736/4885 |
| US-20160053032-A1 | COMPOUND, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | RER1, RFC1, RFC2 | CES2 1498/4885LPAR1 111/4885LPAR3 524/4885 |
| US-20120157421-A1 | 17Beta-Alkyl-17Alpha-oxy-estratrienes | CYP19A1, HSD17B11, CYP17A1 | CES2 784/4885LPAR1 2210/4885LPAR3 1996/4885 |
| US-20150191761-A1 | USE OF HIGH FLUX SCFA-DERIVATIZED MONOSACCHARIDES IN RECOMBINANT GLYCOPROTEIN PRODUCTION | SLC35A1, FUT5, SLC17A5 | CES2 1651/4885LPAR1 1636/4885LPAR3 1490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.